Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 10,602 | 8,842 | 8,045 | 10,091 | 10,736 |
| Operating Income | -10,602 | -8,842 | -8,045 | -10,091 | -10,736 |
| Interest Expense | 407 | 337 | 426 | 194 | 176 |
| Other Income | -814 | 1,461 | -1,612 | -276 | -297 |
| Pre-tax Income | -11,823 | -7,718 | -10,083 | -10,561 | -11,209 |
| Net Income Continuous | -11,823 | -7,718 | -10,083 | -10,561 | -11,209 |
| Net Income | $-11,823 | $-7,718 | $-10,083 | $-10,561 | $-11,209 |
| EPS Basic Total Ops | -0.65 | -0.45 | -0.60 | -0.66 | -0.87 |
| EPS Basic Continuous Ops | -0.65 | -0.46 | -0.60 | -0.66 | -0.87 |
| EPS Diluted Total Ops | -0.65 | -0.45 | -0.60 | -0.66 | -0.87 |
| EPS Diluted Continuous Ops | -0.65 | -0.46 | -0.60 | -0.66 | -0.87 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.49 | -0.60 | -0.66 | -0.87 |
| EBITDA(a) | $-10,245 | $-8,374 | $-7,762 | $-9,810 | $-10,423 |